THE LESER–TRÉLAT SIGN AS A PARANEOPLASTIC MANIFESTATION OF MALIGNANCY: A REVIEW OF THE LITERATURE
Abstract
Introduction/Objective: The Leser–Trélat sign is a paraneoplastic dermatosis characterized by the sudden, eruptive appearance and rapid increase in number and size of multiple seborrheic keratoses, often accompanied by intense pruritus. This clinical presentation may raise suspicion of an underlying malignancy. Although its exact pathophysiological mechanism remains unclear, tumor-derived growth factors are believed to stimulate keratinocyte proliferation, contributing to the abrupt development of lesions. In the literature, the Leser–Trélat sign is most frequently associated with gastrointestinal adenocarcinomas, particularly gastric carcinoma, but it has also been reported in connection with other solid tumors and hematologic malignancies. Given its potential association with occult neoplasm, the appearance of the Leser–Trélat sign warrants a thorough clinical evaluation and systematic diagnostic workup, as timely recognition may facilitate early detection of the underlying malignancy. The aim of the paper is to analyze data from the available literature on the etiology, pathogenesis, and clinical associations of the Leser–Trélat sign with various malignancies, and to evaluate its diagnostic and prognostic significance in contemporary clinical practice.
Methods: A literature review was conducted using the PubMed database, including available original articles, review papers, case reports, and case series. The search was performed using the following keywords: “Leser–Trélat sign”, “paraneoplastic dermatosis”, “seborrheic keratoses”, and “malignancy”.
Conclusion: Awareness of the Leser–Trélat sign and a multidisciplinary approach to investigating its association with malignancies are crucial for the early detection of neoplasms. Recognition of the Leser–Trélat sign may enable the diagnosis of malignancy at a stage when therapeutic response is more favorable, thereby significantly improving disease prognosis.
References
Silva JA, Mesquita Kde C, Igreja AC, Lucas IC, Freitas AF, Oliveira SM, et al. Paraneoplastic cutaneous manifestations: concepts and updates. An Bras Dermatol. 2013 Jan-Feb;88(1):9-22. doi: 10.1590/s0365-05962013000100001.
Ortega-Loayza AG, Ramos W, Gutierrez EL, Paz PC, Bobbio L, Galarza C. Cutaneous manifestations of internal malignancies in a tertiary health care hospital of a developing country. An Bras Dermatol. 2010 Sep-Oct;85(5):736-42. doi: 10.1590/s0365-05962010000500026.
Bártholo RM, Bártholo TP, Florião RA. Leser-Trélat: Um sinal clínico revisitado [Leser-Trélat: A revisited clinical sign]. Pulmão RJ. 2009;18(1):53-6. Portuguese.
Ehst BD, Minzer-Conzetti K, Swerdlin A, Devere TS. Cutaneous manifestations of internal malignancy. Curr Probl Surg. 2010 May;47(5):384-445. doi: 10.1067/j.cpsurg.2010.01.003.
Handjani F, Radanfar R, Sepaskhah M, Dehdari Ebrahimi N. COVID-19 infection and Leser-Trelat sign: Is there an association? Clin Case Rep. 2023 Jul 4;11(7): e7638. doi: 10.1002/ccr3.7638.
Bernett CN, Davidson CL, Schmieder GJ. Leser-Trélat Sign. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan– [updated 2024 Feb 25; cited 2026 Feb 21]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470554/.
Fasoldt JJ, Brumwell ER, Lackey JN. Leser-Trélat sign presenting in a patient with recurrent pre-B-cell acute lymphocytic leukemia. Cutis. 2012 Jan;89(1):33-5.
Hafner C, Vogt T. Seborrheic keratosis. J Dtsch Dermatol Ges. 2008 Aug;6(8):664-77. English, German. doi: 10.1111/j.1610-0387.2008.06788.x.
Grob JJ, Rava MC, Gouvernet J, Fuentes P, Piana L, Gamerre M, et al. The relation between seborrheic keratoses and malignant solid tumours. A case-control study. Acta Derm Venereol. 1991;71(2):166-9. doi: 10.2340/0001555571166169.
Safa G, Darrieux L. Leser-Trélat Sign without Internal Malignancy. Case Rep Oncol. 2011 Mar 29;4(1):175-7. doi: 10.1159/000327363.
Suening BS, Neidenbach PJ. The Pseudo-Sign of Leser-Trélat: A Rare Presentation. Cureus. 2023 Feb 18;15(2):e35155. doi: 10.7759/cureus.35155.
Husain Z, Ho JK, Hantash BM. Sign and pseudo-sign of Leser-Trélat: case reports and a review of the literature. J Drugs Dermatol. 2013 May;12(5):e79-87.
Modi K, Chen R, Abubshait L. Leser-Trélat Sign as a Marker for Underlying Pancreatic Cancer. Clin Pract Cases Emerg Med. 2023 Aug;7(3):202-4. doi: 10.5811/cpcem.1248.
Ramos-E-Silva M, Carvalho JC, Carneiro SC. Cutaneous paraneoplasia. Clin Dermatol. 2011 Sep-Oct;29(5):541-7. doi: 10.1016/j.clindermatol.2010.09.022.
Chakradeo K, Narsinghpura K, Ekladious A. Sign of Leser-Trélat. BMJ Case Rep. 2016 Apr 8;2016:bcr2016215316. doi: 10.1136/bcr-2016-215316.
Moscarella E, Brancaccio G, Briatico G, Ronchi A, Piana S, Argenziano G. Differential Diagnosis and Management on Seborrheic Keratosis in Elderly Patients. Clin Cosmet Investig Dermatol. 2021 Apr 28;14:395-406. doi: 10.2147/CCID.S267246.
Dourmishev LA, Draganov PV. Paraneoplastic dermatological manifestation of gastrointestinal malignancies. World J Gastroenterol. 2009 Sep 21;15(35):4372-9. doi: 10.3748/wjg.15.4372.
Sperry K, Wall J. Adenocarcinoma of the stomach with eruptive seborrheic keratoses: the sign of Leser-Trélat. Cancer. 1980 May 1;45(9):2434-7. doi: 10.1002/1097-0142(19800501)45:9<2434::aid-cncr2820450932>3.0.co;2-m.
Geber A, Hadžavdić A, Ljubojević Hadžavdić S. The Leser-Trélat Sign in a Patient with Gastric Adenocarcinoma. Acta Dermatovenerol Croat. 2023 Aug;31(1):51-2.
Gualtieri B, Hertl M. Seltene Erkrankungen an der Haut erkennen [Recognize rare diseases on the skin]. Internist (Berl). 2019 Feb;60(2):193-201. German. doi: 10.1007/s00108-018-0548-5.
Sardon C, Dempsey T. The Leser-Trélat sign. Cleve Clin J Med. 2017 Dec;84(12):918. doi: 10.3949/ccjm.84a.17021.
Shamsadini S, Wadji MB, Shamsadini A. Surrounding ipsilateral eruptive seborrheic keratosis as a warning sign of intraductal breast carcinoma and Paget's disease (Leser Trelat sign). Dermatol Online J. 2006 Oct 31;12(6):27. doi: 10.5070/D36d36q0nw.
Al Ghazal P, Körber A, Klode J, Dissemond J. Leser-Trélat sign and breast cancer. Lancet. 2013 May 11;381(9878):1653. doi: 10.1016/S0140-6736(12)61257-4.
Aouali S, Bensalem S, Saddouk H, Aissaoui A, Bennani A, Zizi N, et al. Leser-Trelat sign preceding male breast cancer. Ann Med Surg (Lond). 2021 Nov 13;72:103065. doi: 10.1016/j.amsu.2021.103065.
Lynch HT, Fusaro RM, Pester JA, Lynch JF. Leser-Trelat sign in mother and daughter with breast cancer. J Med Genet. 1982 Jun;19(3):218-21. doi: 10.1136/jmg.19.3.218.
Heaphy MR Jr, Millns JL, Schroeter AL. The sign of Leser-Trélat in a case of adenocarcinoma of the lung. J Am Acad Dermatol. 2000 Aug;43(2 Pt 2):386-90. doi: 10.1067/mjd.2000.104967.
Hattori A, Umegae Y, Kataki S, Nakajima T. Small cell carcinoma of the lung with Leser-Trélat sign. Arch Dermatol. 1982 Dec;118(12):1017-8. doi: 10.1001/archderm.1982.01650240061024.
Dasanu CA, Alexandrescu DT. Bilateral Leser-Trélat sign mirroring lung adenocarcinoma with early metastases to the contralateral lung. South Med J. 2009 Feb;102(2):216-8. doi: 10.1097/SMJ.0b013e31818f604d.
Mathien A, Kuraitis D. Leser-Trelat sign: Eruptive seborrheic keratoses and primary lung adenocarcinomas with an epidermal growth factor receptor mutation. JAAD Case Rep. 2023 May 4;37:38-40. doi: 10.1016/j.jdcr.2023.04.022.
Gori N, Esposito I, Del Regno L, D'Amore A, Peris K, Di Stefani A. Leser-Trélat sign as a rare manifestation of cutaneous melanoma. Dermatol Reports. 2020 Jul 6;12(1):8665. doi: 10.4081/dr.2020.8665.
Silveri OC, James F, Dickens B. Variability of Leser-Trélat Sign Secondary to Melanoma In Situ. Cureus. 2024 Feb 5;16(2):e53639. doi: 10.7759/cureus.53639.
Siedek V, Schuh T, Wollenberg A. Leser-Trelat sign in metastasized malignant melanoma. Eur Arch Otorhinolaryngol. 2009 Feb;266(2):297-9. doi: 10.1007/s00405-008-0636-6.
Patton T, Zirwas M, Nieland-Fisher N, Jukic D. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat. J Drugs Dermatol. 2004 Sep-Oct;3(5):565-6.
Dobrev H. The Sign of Leser-Trélat as a Possible Indicator of Prostate Adenocarcinoma: A Case Report. Prostate. 2026 May;86(6):732-4. doi: 10.1002/pros.70137.
Okur A, Şahin KC, Sahin Z, Gultekin MH, Onal B. Leser-Trélat Sign as an Initial Manifestation of Synchronous Prostate and Bladder Cancer. Cureus. 2025 Sep 27;17(9):e93325. doi: 10.7759/cureus.93325.
Narala S, Cohen PR. Cutaneous T-cell lymphoma-associated Leser-Trélat sign: report and world literature review. Dermatol Online J. 2017 Jan 15;23(1):13030/qt0w01b1t3.
Alsaif F, Alkhayal FA, Aldahash R, Alhumaidi A. Leser-Trélat Sign Presenting in a Patient with Relapsing Mycosis Fungoides. Case Rep Oncol. 2018 Jun 29;11(2):436-41. doi: 10.1159/000490527.
André R, Laffitte E, Abosaleh M, Cortès B, Toutous-Trellu L, Kaya G. Sign of Leser-Trélat and Cutaneous T-Cell Lymphoma: A Rare Association. Dermatopathology (Basel). 2018 May 25;5(2):69-73. doi: 10.1159/000488982.
McCrary ML, Davis LS. Sign of Leser-Trélat and mycosis fungoides. J Am Acad Dermatol. 1998 Apr;38(4):644. doi: 10.1016/s0190-9622(98)70143-4.
Cohen JH, Lessin SR, Vowels BR, Benoit B, Witmer WK, Rook AH. The sign of Leser-Trélat in association with Sézary syndrome: simultaneous disappearance of seborrheic keratoses and malignant T-cell clone during combined therapy with photopheresis and interferon alfa. Arch Dermatol. 1993 Sep;129(9):1213-5. doi: 10.1001/archderm.1993.01680300143034.
Halevy S, Halevy J, Feuerman EJ. The sign of Leser-Trélat in association with lymphocytic lymphoma. Dermatologica. 1980;161(3):183-6. doi: 10.1159/000250355.
Thiers BH, Sahn RE, Callen JP. Cutaneous manifestations of internal malignancy. CA Cancer J Clin. 2009 Mar-Apr;59(2):73-98. doi: 10.3322/caac.20005.
Nagata M, Otani S, Kanai Y, Yamamoto S, Tsubochi H, Endo S. Laser-Trélat sign improved after the resection of a tiny ground-grass nodule: a case report. J Surg Case Rep. 2021 Jun 29;2021(6):rjab275. doi: 10.1093/jscr/rjab275.
